Free EHR, EHR and Healthcare IT Newsletter Want to receive the latest updates on EHR, EMR and Healthcare IT news sent straight to your email? Get all the latest EHR News for FREE!

3-D Printed Facial Prosthesis Offers New Hope for Eye Cancer Patients Following Surgery

Made to cover hollow eye sockets, flexible custom masks provide more affordable, fast- production alternative to traditional prosthetics

CHICAGO – Researchers have developed a fast and inexpensive way to make facial prostheses for eye cancer patients using facial scanning software and 3-D printing, according to findings released today at AAO 2014, the 118th annual meeting of the American Academy of Ophthalmology. Their novel process can create more affordable prosthetics for any patients who have hollow sockets resulting from eye surgery following cancer or congenital deformities.

In the United States, more than 2,700 new cases of eye cancer are diagnosed each year, according to the American Cancer Society, and the mortality rate is high for the disease. Some patients undergo a life-saving surgery known as exenteration that involves removing the contents of the eye socket and other tissue. The research team hopes to bring these patients relief by providing a more affordable facial prosthesis that will allow them to live their lives more fully and with less stigma.

Conventional facial prostheses can cost $10,000 to $15,000 and take weeks to produce. Each one is created by an ocularist, an artisan who makes a mold of the face, casts it using rubber and then adds the final touches such as skin color and individual eyelashes. Patients and their families often have to pay out-of-pocket for facial prostheses because health insurance oftentimes will not cover the cost.

University of Miami researchers developed a process to manufacture facial prostheses in a matter of hours at a fraction of the cost of a traditional prosthesis using topographical scanning and 3-D printing technology. Patients are scanned on the undamaged side of their face using a mobile scanner. The software then creates a mirror image. Along with a scan of the side of the face with the orbital defect, the program can mesh the two scans together to create a 3-D image of the face. The topographical information then goes to a 3-D printer, which translates the data into a mask formed out of injection-molded rubber suffused with colored pigments matching the patient’s skin tone.

The project started as the brainchild of David Tse, M.D., professor of ophthalmology at the Bascom Palmer Eye Institute in Florida and the Nasser Ibrahim Al-Rashid chair in ophthalmic plastic, orbital surgery and oncology. Dr. Tse was treating a child with eye cancer who had both eyelids removed and underwent exenteration. The family could not afford an ocularist, so Dr. Tse raised donations to help pay for her first prosthesis. Now a teenager, she has grown out of the prosthesis and must instead wear an eye patch.

“Hopefully, using this quick and less expensive 3-D printing process, we can make an affordable facial prosthesis for her and also help thousands of other people like her who lack the resources to obtain one through an ocularist,” said Dr. Tse.

Designed and developed in partnership with Dr. Tse and a team at the Composite Materials Lab at the University of Miami, the 3-D printed prosthesis possesses several advantages over the conventional type created by an ocularist. The material involves a proprietary mix of nanoparticles that provides extra reinforcement and makes it possible to match many shades of skin. Over time, conventional facial prostheses can discolor and fray at the edges, but nanoclay protects the material from breaking down and changing color when exposed to moisture and light. It also prevents dirt from depositing. If the prosthesis ever needs to be replaced, reproduction can happen with the press of a button.

“Once we have a patient scanned, we have the mold, so we can create a new prosthesis in no time,” said Landon Grace, Ph.D., director of the lab and an assistant professor of mechanical and aerospace engineering. “Our long-term goal is to help patients anywhere in the world. We could get a mobile scan, download the data in Miami, print out the prosthesis and ship it back to the patient the next day.”

Rapid and cost-effective orbital prosthesis fabrication via automated non-contact facial topography mapping and 3-D printing (PO467) was presented at AAO 2014, the 118th annual meeting of the American Academy of Ophthalmology in conjunction with the European Society of Ophthalmology, which is in session October 18-21 at McCormick Place in Chicago. More than 25,000 attendees and 620 companies from 123 countries gather each year to showcase the latest in ophthalmic education, research and technology. To learn more about the event Where All of Ophthalmology Meets, visit http://www.aao.org/2014.

More 3-D Printing Technology Research

Additional 3-D printing technology results will be presented at AAO 2014 by ophthalmologist David Myung, M.D., Ph.D., of the Byers Eye Institute at Stanford University. His work centers on a 3-D-printed lens adapter system that enables high quality images of the eye using smartphones, which may help increase access to more affordable eye care. The poster is titled “Design and Rapid Prototyping of a Novel 3-D Printed Smartphone Lens Adapter System” (PO328).

About the American Academy of Ophthalmology
The American Academy of Ophthalmology, headquartered in San Francisco, is the world’s largest association of eye physicians and surgeons, serving more than 32,000 members worldwide.  The Academy’s mission is to advance the lifelong learning and professional interests of ophthalmologists to ensure that the public can obtain the best possible eye care. For more information, visit www.aao.org.

The Academy is also a leading provider of eye care information to the public. The Academy’s EyeSmart® program educates the public about the importance of eye health and empowers them to preserve healthy vision. EyeSmart provides the most trusted and medically accurate information about eye diseases, conditions and injuries. OjosSanos™ is the Spanish-language version of the program. Visit www.geteyesmart.org or www.ojossanos.org to learn more.

October 17, 2014 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 15 blogs containing almost 6000 articles with John having written over 3000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 13 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit.

Tute Genomics Biomarker Discovery Platform to Support Brigham Young University’s Alzheimer’s Disease Genetics Research

Provo, Utah (July 22, 2014)  — Tute Genomics today announced that its genome annotation and discovery platform will support Brigham Young University’s (BYU) efforts to advance Alzheimer’s disease genetics research. This collaboration involves analysis and interpretation of next-generation sequencing data from more than 1,000 exomes and genomes to identify new genetic variants associated with the disease.

“Collaboration is the key to discovering novel variants in genomics research, and Tute Genomics is honored to play a role in supporting this important work,” said Dr. Kai Wang, President of Tute Genomics, “This is an example of how our platform significantly enhances the ability for researchers to identify disease genes and variants from thousands of genomes.”

Dr. John “Keoni” Kauwe is leading a group of scientists from the BYU College of Life Sciences that is leveraging Tute Genomics in a large-scale effort to better understand the genetic basis of Alzheimer’s disease. The causes of this brain disease are still not fully understood and traditional treatments have so far proven unsuccessful. Dr. Kauwe’s group is looking to utilize Tute Genomics’ biomarker discovery platform to identify novel targets that may be used for therapeutic interventions.

“We have been extremely impressed with the Tute platform thus far, and we already have a number of research findings we are evaluating. We are excited to utilize Tute’s technology to support our novel approaches to finding genetic variants associated with Alzheimer’s disease using exome and whole genome sequence data,” said Dr. Kauwe.

The Alzheimer’s Genetic Analysis Group is a collaborative effort led by Dr. John Hardy at University College London. Other Principal Investigators in this group include Dr. Kauwe from BYU, Drs. Alison Goate and Carlos Cruchaga at the Washington University School of Medicine, and Dr. Andrew Singleton at the National Institutes of Health. Late last year this group discovered a novel genetic variant that doubles a person’s risk of developing the disease later in life. The study included families that had several members with Alzheimer’s. The scientists sequenced and compared genes of those individuals affected by the disease and those who were not. They were then able to identify variations in a gene that appeared in affected family members. [1]

Another of their recent studies has helped lift the veil on some of the mystery surrounding the causes of Alzheimer’s. The research team analyzed data from more than 25,000 people and reported that a rare genetic mutation in TREM2, a gene with function in the immune and inflammatory response, increases the risk of Alzheimer’s disease. [2]

“Dr. Kauwe and the Alzheimer’s Genetic Analysis Group are making exciting progress towards understanding the genetic underpinnings of Alzheimer’s disease. The first step towards effective treatments and an eventual cure is to fully understand the genetics and neurobiology of the disorder,” said Dr. Reid Robison, co-founder and CEO of Tute Genomics.

About Tute Genomics

Tute Genomics is a Utah-based company developing innovative cloud-based solutions to accelerate genetic discovery and enable precision medicine. Tute developed a clinical genome interpretation platform that assists researchers in identifying disease genes and biomarkers, and assists clinicians/labs in performing genetic diagnosis. Given sequencing data on a genome or a panel of genes, Tute can return over 125 annotations on variants and genes, perform family-based, case/control or tumor sample analyses to identify causal disease genes, and generate clinical reports for clinicians to focus on clinically relevant and actionable findings. Tute is built on the expertise that developed ANNOVAR, the most widely used genome annotation & interpretation technology with over 750 scientific citations. To learn more please visit www.tutegenomics.com.

[1] “Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer’s disease.” Nature. 2014 Jan 23;505(7484):550-4. doi: 10.1038/nature12825.

[2] “TREM2 variants in Alzheimer’s disease.” New England Journal of Medicine. 2013 Jan 10;368(2):117-27. doi: 10.1056/NEJMoa1211851.

July 22, 2014 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 15 blogs containing almost 6000 articles with John having written over 3000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 13 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit.

M*Modal Drives Anywhere, Anytime Medical Dictation with Enhancements to iOS Mobility Solution

Understanding that physicians require more comprehensive, flexible clinical documentation solutions that reflect the fast-paced highly mobile health care environment, M*Modal today announced enhancements to its Fluency Flex™ Mobile dictation application for iOS 6.0+ devices. Moving beyond the capture of clinical notes during patient encounters to more robust clinical documentation, the new application allows physicians to select a patient from their appointment schedule to quickly and accurately record clinical notes, improving ease of use and productivity.

“M*Modal Fluency Flex Mobile gives physicians a robust dictation solution—right in their pocket,” said Duncan James, CEO of M*Modal. “This app allows them to dictate on their terms to help them save time, streamline their workflow, and ultimately deliver better care.”

M*Modal Fluency Flex Mobile connects doctors with hospital information systems to access health records and dictate and review notes during patient encounters or on the go. The app captures high-quality audio which is securely and immediately transmitted to the M*Modal Fluency for Transcription™ speech engine for fast text conversion and transfer to electronic medical record (EMR) systems.

M*Modal Fluency Flex Mobile includes the following features:

  • Physicians can select a patient from their appointment schedule with real-time updates when connected to hospital interfaces
  • Online and offline voice capture, leveraging 3G and Wi-Fi connectivity for uploading dictations
  • Ability to play back “in process” dictation and suspend jobs for later review/resume/completion
  • Improved audio quality compared to using mobile carrier voice networks by leveraging the latest noise reduction technology on the iPhone
  • Security features meeting HIPAA guidelines including unique authentication, inactivity timeout, encryption of data on device, secure communication over SSL

The app builds on the same cloud-based M*Modal Speech Understanding™ technology powering all M*Modal solutions, so existing clinician voice profiles can be used easily and instantly for optimal accuracy. The M*Modal Fluency™ family of products give healthcare providers the freedom to choose workflow options – mobile, front- and back-end speech recognition, traditional transcription – that best meet their needs.

The M*Modal Fluency Flex™ Mobile app is certified to run on the iPhone® and can work on any device running iOS v6.0 and above. The app is available in the iTunes App Store and is free to customers of M*Modal’s Fluency for Transcription platform.

For more information on M*Modal please visit www.mmodal.com or follow on Twitter@MModal.

iPhone® is a registered trademark of Apple Inc.

# # #

About M*Modal

M*Modal is a leading healthcare technology provider of advanced clinical documentation solutions, enabling hospitals and physicians to enrich the content of patient electronic health records (EHR) for improved healthcare and comprehensive billing integrity. As one of the largest clinical transcription service provider in the U.S., with a global network of medical editors, M*Modal also provides advanced cloud-based Speech Understanding™ technology and data analytics that enable physicians and clinicians to include the context of their patient narratives into electronic health records in a single step, further enhancing their productivity and the cost-saving efficiency and quality of patient care at the point of care. For more information, please visit www.mmodal.comTwitterFacebook and YouTube.

May 5, 2014 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 15 blogs containing almost 6000 articles with John having written over 3000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 13 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit.

Zoeticx Offers Medical Professionals Hands-Free Access to its Software Applications by Integrating Nuance’s Speech Recognition Technology

Caregivers on the Go can Conveniently Access Any Zoeticx Application with Simple Voice Commands 

Orlando, Fla. – February 23, 2014 – Zoeticx, Inc., the developer of medical software that improves patient outcomes by bridging the gap between medical data and quality care, announced its integration of Nuance’s SpeechAnywhere technology into its mobile app today at the HIMSS Annual Conference & Exhibition, Nuance Booth #3675, in the Cloud and Mobility Solutions pavilion.

Zoeticx has added Nuance’s voice recognition capability to its cloud-based Patient-Clarity collaborative platform to enable caregivers to use their voice to expand screen panels, scroll left and right, access images, bring up documents and make other screen changes that previously required finger contact.

A dictionary of medical terms and phrases also streamlines use along with the convenience of setting voice recording levels. This hands-free environment enables Zoeticx to provide medical professionals with yet another point of convenience and helps make delivering patient care the top priority.

Recognizing voice data is another benefit Zoeticx offers to help medical professionals make record keeping easier. Other key information facilitators include integration with any EMR database, use of SOA technology, and accessibility over any iOS device.  This integration furthers Zoeticxs’ goal of software innovation with a patient-centric approach.

“Our integration of Nuance’s SpeechAnywhere is another example of our determination to provide medical organizations with the most comprehensive, easy to use set of solutions designed to improve patient outcomes,” said Thanh Tran, CEO, Zoeticx, Inc.

About Zoeticx

Zoeticx offers software solutions for the healthcare industry which are dedicated to improving patient outcomes, enhancing the quality of care, containing costs, and simplifying administration. These solutions offer an immediate increase in the quality of care by delivering the right information to the right caregiver at the right time, in a manner that can be easily understood.  Additionally, as the Affordable Care Act continues to roll out, healthcare providers will face new challenges which arise whenever there is a transition from an old system of doing business to a new one. Zoeticx helps solve those challenges, allowing care providers to focus on what is most important, the patient. www.Zoeticx.com

For additional information contact Glass Lantern PR at contact@glasslanternpr.com .

February 7, 2014 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 15 blogs containing almost 6000 articles with John having written over 3000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 13 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit.

Authasas Adds the Lumidigm Advantage to Its Advanced Authentication Platform

Solution delivers reliable, convenient, secure, and compliant authentication at all points of access across the enterprise

ALBUQUERQUE, NM — October 30, 2012 — Lumidigm today announced that enterprises can now authenticate users with Lumidigm multispectral imaging biometrics as part of an integrated authentication platform from Authasas. With the addition of Lumidigm’s unique capabilities, the Authasas Advanced Authentication® solution is more secure, more convenient, and strongly spoof-resistant. This combined solution delivers the high levels of security, accountability and compliance that organizations are demanding with the single-touch convenience they expect.

“Because of Lumidigm’s success in bringing higher levels of performance to border crossings, thousands upon thousands of ATMs and even the gates of major amusement parks, we felt it was important to bring the power of their technology to our customers,” emphasizes Reiner van der Drift, Authasas CEO. “Together we provide a very powerful combination of authentication methods, seamlessly delivered at all points of access, to replace the fragmented array of point solutions that is regrettably the common, makeshift response to today’s complex requirements.”

“With our large-scale successes in the banking and healthcare industries, we know our fingerprint sensors offer convenience and security wherever they are deployed,” says Phil Scarfo, Lumidigm Senior Vice President of Worldwide Sales and Marketing. “Today, in partnership with Authasas, we are expanding our no-compromises approach into comprehensive authentication solutions where multispectral imaging will play an important role in streamlining compliant access for large enterprises requiring seamless transactional authentication.”

The Authasas Advanced Authentication platform lets an enterprise optimize authentication for every transaction by balancing the right level of certainty based on “who” is requesting access with the right level of convenience for the actual user, resulting in a secure, compliant transaction. This flexible, scalable approach meets the size and complexity requirements of any enterprise with authentication methods such as multispectral imaging biometrics, smart cards, NFC, cell phone OTP tokens, USB authenticators and user ID/passwords integrated with a wide variety of SSO and identity management vendors such as NetIQ/Novell, HID ActivIdentity, Oracle, Computer Associates and HealthCast.

About Authasas

With our HQ, Research & Development in The Netherlands and offices in London and Austin, TX, Authasas® delivers strong authentication to Windows networks. Authasas® Advanced Authentication is distributed across the globe via a network of value added distributors and resellers. Authasas is a subsidiary of BioXS International BV. For more information please visit http://www.authasas.com.

About Lumidigm

Lumidigm Inc., a global leader in authentication solutions is dedicated to enabling convenient, secure, and reliable identification of people, products and credentials. Developed with “real world” performance as a priority, Lumidigm’s multispectral imaging technology, innovative software and biometric fingerprint sensors allow customers to know “who” or “what” to a high degree of certainty. Lumidigm and its strategic partners have met challenging authentication requirements in markets such as banking, healthcare, entertainment, and government services. The Lumidigm Advantage is also suitable for industrial, commercial, and transportation applications. Lumidigm is headquartered in Albuquerque, New Mexico. For more information, visit www.lumidigm.com.

November 21, 2012 I Written By

Critical Health Information at Your Fingertips: Low-Cost Technology Turns Smartphones and Mobile Devices into Medical Monitors

Affordable, Accessible, Real-Time Measurement of Blood Oxygen Levels, Blood Pressure and Temperature Through Mobile Devices

Vancouver, B.C. – October 18, 2012 – Lionsgate Technologies Inc. (LGTmedical), a leading provider of mobile health (mHealth) technology, will launch a revolutionary universal interface that transforms smartphones, tablets and laptops into mobile medical diagnostic tools capable of real-time vital signs monitoring.

Using standard medical sensors connected directly through the universal audio port of virtually any mobile device, the proprietary interface, called the Vital Signs DSP™ (Digital Signal Processor), provides precise monitoring of blood oxygen levels, blood pressure and body temperature which are displayed on the mobile device’s monitor.

The availability of an accurate, affordable mobile medical diagnostic tool has sweeping applications in the medical/clinical and consumer markets as well as in the developing world where 64 per cent of mobile phone users are found.

“Pairing medical diagnostics with mobile phones will greatly advance the assessment, diagnosis and treatment of critical diseases in developing countries,” said Dr. Mark Ansermino, Associate Professor, Department of Anesthesiology, Pharmacology and Therapeutics, at the University of British Columbia (UBC), whose team developed the technology.  “The availability of portable, easy-to-use and affordable mobile health monitoring technology will move medical diagnostics from the hospital to non-hospital settings, helping reduce global health inequities and improving health outcomes worldwide.”

LGTmedical’s technology, which includes applications for pulse oximetry, temperature and blood pressure monitoring, requires no external signal processors, microcontrollers, power sources or displays. Users just download a proprietary app that allows their mobile device to drive a low-cost standard medical sensor.

The company plans to launch its flagship product, the Phone Oximeter™, into clinical markets in 2013, with blood pressure and temperature applications to follow. This new technology platform supports ultra-low cost product design, which will make these applications affordable for everyone.  LGTmedical’s mHealth devices are expected to cost between $10 and $40, which is significantly less than competing products on the market today.

The Phone Oximeter™ will enable mobile devices to provide non-invasive measurements of blood oxygen levels. After downloading the app, a standard medical sensor attached to the patient’s finger is connected to the audio port of any phone, tablet or laptop.  The sensor detects concentrations of oxygen in the blood and displays the readings in colorful symbols on the mobile device’s monitor making pulse oximetry easy to use and accessible. (http://www.youtube.com/user/LGTmedical)

The World Health Organization recognizes the importance of making pulse oximetry available and affordable to the developing world.  The diagnosis and treatment of infectious diseases like pneumonia, which claims the lives of two million children under five years of age every year, can be greatly enhanced by affordable pulse oximetry.  There are also large consumer market for mHealth vital signs applications in the areas of chronic disease management, personal care management, sleep apnea and fitness.

Driven by the explosive growth of mobile phones and tablets and the pressing need to improve health outcomes and reduce healthcare costs, the global mHealth market is projected to reach US$ 23 billion by 2017, according to PricewaterhouseCoopers.  Mobile monitoring services will account for the largest share of the global market (approximately 65 per cent), expected to reach US$ 15 billion in 2017.

“Mobile vital signs technology will serve as a valuable tool in assisting with medical diagnosis, decision support, chronic disease management and patient engagement in the coming years,”said Tom Walker, President and CEO of LGTmedical.  “We are proud of our innovations which mark a significant shift in the evolution of mHealth. From headphones to healthcare, making affordable health monitoring tools available to clinicians and consumers will help improve the quality of care, save lives and reduce healthcare costs.”

The Vital Signs DSP™ technology was developed by a research team at the University of British Columbia, the Child & Family Research Institute (CFRI) and BC Children’s Hospital known as Electrical & Computer Engineering in Medicine (ECEM).  Dr. Mark Ansermino and Guy Dumont, Professor of Electrical and Computer Engineering at UBC and a CFRI Scientist, who led the team, received the prestigious Brockhouse Canada Prize for Interdisciplinary Research in Science and Engineering from the Natural Sciences & Engineering Research Council of Canada in 2010 for their work on the Phone Oximeter.

R&D and field testing of the Phone Oximeter™ has been conducted in both North America and emerging markets, such as Uganda, through the generous support of UBC, BC Children’s Hospital, the Bill and Melinda Gates Foundation, Grand Challenges Canada, and other sponsoring foundations and government agencies.

About LGTmedical

LionsGate Technologies (LGTmedical) is a spin-off company out of the University of British Columbia, the Child & Family Research Institute and BC Children’s Hospital. The Vital Signs DSP™ is the company’s proprietary signal processing platform for the development and commercialization of ultra-low cost vital signs monitoring applications in mHealth.  LGTmedical is developing a suite of mHealth technologies to meet the important global need for accurate, accessible and affordable medical diagnostics. For more information, please visit http://lgtmedical.com

November 19, 2012 I Written By

Indigo Identityware Announces Password-free Strong Authentication for Mobile Clinicians

Password-free strong authentication for all clinical computing platforms 

MINNEAPOLIS, MN – February 13, 2012 – Indigo Identityware announces that its password-free strong authentication product, iDNA, has been expanded to address all clinical computing environments. Whether it’s thick, thin or zero client desktops, virtual desktops with VMware™ or Citrix®, or mobile tablets such as iPad®, Android® or Win7®, Indigo’s iDNA™ offers clinicians quick, secure log on without the hassles of passwords.  The user simply has their unique 4-digit PIN, and he or she can utilize any or all of the following environments.

Mobile
iDNA works with any mobile solution including the iPad, Android devices and Win 7 platforms. Clinicians who like to use their iPad or other mobile devices to access their clinical desktop and/or applications can do so without security concerns. Whether they are managed or unmanaged devices, Indigo securely and simply logs users in with a four-digit personal identification number (PIN).

Managed Desktops
Most clinicians’ work gets done within the enterprise. And, just like Indigo works with mobile and independent desktops, iDNA also works within a managed desktop environment. In fact, Indigo’s solution eliminates help desk calls as a result of forgotten passwords as iDNA does not use complicated passwords to securely log users in. Whether it’s Indigo’s next-generation biometric solution or its proximity card and PIN, Indigo quickly and safely logs users in and out of their desktops.

Virtual Desktops

Many clinical establishments are moving to virtual platforms, with the use of Citrix, VMware or Terminal Services®, to help with the overall management and administration of complex clinical environments that include multitudes of clinical applications and EMRs. Virtual environments also enable clinicians the flexibility to roam about within their enterprise and access their desktop from any location. Indigo iDNA works with all virtual platforms and ensures users complete security for HIPAA compliance.

Independent Desktops
iDNA is compatible with independent desktops outside of the domain and not requiring access control, such as Win 7, Win XP® and soon to include Linux® and Mac®. Users access their desktop outside of their managed enterprise, and then securely log in using iDNA.

To learn more about Indigo Identityware and its revolutionary strong authentication solution, iDNA, please visit us at HIMSS12 (Health Information Management Systems Society) in Las Vegas, Nevada, February 21-23, in Booth 4059.

About Indigo

Indigo Identityware, a leader in the identity and access management industry, distinguishes itself by providing password-free mobile and virtual strong authentication. Indigo’s software-only architecture was built from the ground up for mobile, virtual and clinical cloud computing. This differentiates Indigo from all other identity management solutions. Indigo’s solution works in any virtual environment and has been certified as Citrix Ready. Its flexible design supports multiple strong authentication methods, including next generation biometrics, providing users with secure and fast access to information. Indigo’s software-only solution increases workflow productivity while helping customers ensure regulatory compliance. To learn more, visit www.indigoidware.com.

February 14, 2012 I Written By

Lumidigm Names Mark Shermetaro Chief Executive Officer

Bob Harbour to Stay on as Executive Chairman

ALBUQUERQUE, NM — February 2, 2012 — Lumidigm Inc., the multi-imaging biometric identity management company, today announced that its Board of Directors has appointed Lumidigm Board member Mark Shermetaro as CEO. Lumidigm Co-founder, Chairman and CEO Bob Harbour will stay on as Executive Chairman of the Board of Directors, effective February 1.

“We are fortunate to be able to bring someone with Mark Shermetaro’s market-focused business development skills and experience to Lumidigm during this period of rapid revenue growth and ambitious product development,” said Harbour. “After three successive years of sustained growth and record revenues, the stage is set to accelerate the maturation of this company with someone with Mark’s skills and experience at the helm.”

Shermetaro said, “As a Board member I have been impressed by Lumidigm’s development into a profitable enterprise with industry-leading products and a rich portfolio of intellectual property. I am excited to join the Lumidigm executive team during this dynamic time in the company’s development and to continue my close working relationship with Bob and the rest of the Board and Investor Group.”

Shermetaro comes to Lumidigm from his position as Vice President of Business Development at Methode Electronics, where he was responsible for leading corporate M&A activity. Shermetaro served on the Lumidigm Board of Directors for two years.

About Lumidigm

Lumidigm Inc., the multispectral imaging biometrics company, is dedicated to enabling convenient, secure, and reliable identification and verification. Lumidigm fingerprint sensors capture superior images quickly, on all people, in all conditions. Everyone can be enrolled. Everyone can be verified. Lumidigm’s sensors are quick and easy to use — perfect for any application in which speed, security and reliability are paramount. Headquartered in Albuquerque, New Mexico, Lumidigm sensors are distributed worldwide. Lumidigm’s initial venture capital investors are DFJ New England, Draper Fisher Jurvetson, Epic Ventures, Intel Capital, International Venture Fund and Solstice Capital. Other investors include Methode Electronics, Motorola Solutions Venture Capital, New Mexico Co-Investment Partners managed by Fort Washington Capital, and Sun Mountain Capital. For more information, visit www.lumidigm.com.

February 5, 2012 I Written By

Independa Unveils Health Measures at CES 2012 Digital Health Summit– An Easy, Affordable Option for Home Health Monitoring

Independa announced, during the Consumer Electronics Show, Health Measures– a simple, affordable option to enhance remote health monitoring of the elderly that doesn’t require wireless infrastructure in a home.

The new service will integrate conventional telephony with Independa’s cloud-based services to enable professional and family caregivers to easily record biometric information using only a wireline or mobile phone and have it merged with other data presented on the Independa Caregiver Web app.

This announcement will follow Independa’s announcement of a collaboration with LG to offer an industry-first suite of TV-based services specifically for long-term care facilities. That offering will provide Independa’s cloud-based Angela™ application on LG Electronics’ Pro:Centric™-enabled commercial televisions designed for the unique needs of communities for the elderly.

Cloud-Based Service Works with Any Wireline or Mobile Phone, Allowing Convenient Monitoring of the Elderly

SAN DIEGO, Jan. 11, 2012Independa today announced plans during the 2012 International CES for Health Measures – a platform combining conventional telephony with existing Independa cloud-based services to improve remote care for the elderly.

Simple, affordable Health Measures doesn’t require cellular coverage, broadband service or wireless devices in the home, making it ideal for care recipients who live in rural areas with poor cellular coverage, have limited funds to invest in wireless health devices, or have limited time to implement wireless health monitoring solutions immediately after leaving the hospital.

Health Measures allows home-health and home-care professionals, as well as senior-living facilities and family caregivers, to easily record a multitude of crucial biometric data, including weight, blood pressure, glucose level, temperature, pulse and heart rate. Information entered using a wireline or mobile phone is converted to digital form and delivered to Independa’s cloud-based telecare solution. All information collected is merged with other data to provide a complete and perpetual view of a person’s body telemetry and bio-informatics. The information is presented on the Independa Caregiver Web App, which also enables caregivers to create and follow responses to automatic reminders for those being cared for to take their medications, exercise, eat, hydrate and keep medical appointments.

“We have designed Health Measures to help mitigate expensive and often debilitating conditions that commonly arise during transitions in care,” said Independa CEO Kian Saneii. “Our new service will enable hospitals, other caregiving organizations and family caregivers to begin monitoring a care recipient’s biotelemetry as soon as the person returns to their residence. Professional and family caregivers will receive timely information, avoiding the need for time-consuming and costly routine home visits.

“Health Measures offers a convenient, intuitive way to provide better, more cost-effective care for elderly people who need remote observation but whose residences don’t have the technological infrastructure for sophisticated wireless health monitoring solutions,” said Dr. Richard Della Penna, Independa Chief Medical Officer and former Kaiser Permanente national eldercare lead. “Considering that most conditions requiring a return to the hospital emerge in the first three days after discharge, Health Measures provides hospitals and other healthcare organizations new opportunities to avoid readmissions and related Medicare and Medicaid penalties.”

Independa plans to make Health Measures available in February after a month of pilot testing. Health Measures offers a no-hardware, no-installation, lower-cost alternative to complement Independa’s Artemis™ solution, a wireless health and home sensor platform. The same alerts and thresholds apply, whether health information is received conveniently via a telephone or a wireless health device.

Health Measures and Artemis both build on the Caregiver Web App and on Independa’s touchscreen-based Angela™ offering, which focuses on social engagement for the care recipient. Angela provides single-touch access to games, puzzles, favorite websites, video Web chat, Facebook, email, a photo album and a calendar planner, as well as health-metrics reporting.

For more information about Health Measures, visit www.independa.com/health-measures.

About Independa, Inc.

Independa offers leading technology-enabled independent-living solutions. Independa’s best-of-breed cloud-based services enable organizations and individuals providing eldercare to cost-effectively allow the elderly to stay home longer, safer and more comfortably. Independa Integrated CloudCare services include medication and appointment reminders, support for activities of daily living, comprehensive social engagement benefits, and wireless health and safety monitoring.

January 15, 2012 I Written By

Lumidigm’s Multispectral Imaging Sensor Biometrically Enhances Innometriks’ Cheetah Reader

Innometriks has added Lumidigm’s Mercury multispectral biometric sensor to the Innometriks Cheetah card reader, which meets or exceeds credential authentication requirements as set forth by the U.S. Government identity programs including FIPS201/PIV, SP800-116 and the Transportation Worker’s Identity Credential (TWIC).  Mercury biometric sensors feature multispectral imaging, a sophisticated technology developed to overcome the fingerprint capture problems conventional imaging systems have in less-than-ideal conditions.

Next Generation Card Reader Solution for Strong Identity Authentication and Smart Card Access Control Systems

To Be Showcased at Lumidigm ASIS Booth 2937 Biometric Consortium Conference – Lumidigm Booth 311 – September 27-29 

ALBUQUERQUE, NEW MEXICO – September 19, 2011 – Lumidigm today announced that Innometriks has added Lumidigm’s Mercury multispectral biometric sensor to the Innometriks Cheetah card reader, which meets or exceeds credential authentication requirements as set forth by U.S. Government identity programs including FIPS201/PIV, SP800-116 and the Transportation Worker’s Identity Credential (TWIC).  Mercury biometric sensors feature multispectral fingerprint imaging, a sophisticated technology developed to overcome the capture problems conventional imaging systems have in less-than-ideal conditions.

“Multispectral imaging from Lumidigm lets our Cheetah reader capture superior fingerprint images quickly on all people in all environmental conditions,” emphasizes John Cassise, Innometriks CEO.  “The Mercury sensors incorporate this field-proven technology into a reliable platform that allows for a smaller form factor and a lower cost.”

“Our Mercury multispectral sensors coupled with the Cheetah’s strong credential authentication provide a truly cost-effective reader for those who are serious about the entire security process,” adds Bill Spence, Lumidigm vice president, transaction services.  “Security professionals now have a reader that seamlessly connects the next generation of credentials with the next generation of reliable fingerprint technology.”

Lumidigm Mercury multispectral fingerprint sensors capture fingerprint data beneath the surface of the skin so that dryness or even damaged or worn fingers create no problems for reliable reads.  Using multiple wavelengths of light and advanced polarization techniques to extract unique fingerprint characteristics from both the surface and subsurface of the skin, the sensors provide Cheetah users with results that are more consistent, more inclusive and more tamper resistant than conventional biometric readers using an optical technology.

The Innometriks Cheetah reader and Lumidigm’s new Mariner fingerprint reader will be showcased at ASIS in Orlando, September 19-21 in Lumidigm booth 2937 and at Biometrics Consortium Conference in Tampa, September 27-29 in Lumidigm booth 311.

About Innometriks

Innometriks develops and manufactures a suite of hardware and software products that provide strong identity authentication for mission critical environments.  Strong identity authentication verifies an individual’s identity using technologies including biometrics, Public Key Infrastructure (PKI) and digital signatures, providing greater protection of critical assets and sensitive information.  Innometriks innovative and comprehensive application suite offers credential validation and registration on a platform that is open, scalable and extensible.  www.innometriks.com

About Lumidigm

Lumidigm Inc., the multispectral imaging biometrics company, is dedicated to enabling convenient, secure, and reliable identification and verification. Lumidigm fingerprint sensors capture superior images quickly, on all people, in all conditions. Everyone can be enrolled. Everyone can be verified. Lumidigm’s sensors are quick and easy to use — perfect for any application in which speed, security and reliability are paramount. Headquartered in Albuquerque, New Mexico, Lumidigm sensors are distributed worldwide. Lumidigm’s initial venture capital investors are DFJ New England, Draper Fisher Jurvetson, Epic Ventures, Intel Capital, International Venture Fund and Solstice Capital. Other investors include Methode Electronics, Motorola Ventures, New Mexico Co-Investment Partners managed by Fort Washington Capital, and Sun Mountain Capital. For more information, visit www.lumidigm.com.

September 28, 2011 I Written By